A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …

Highlights•This Clinical Practice Guideline provides management recommendations for
patients with brain metastases from solid tumours.•The guideline covers clinical and …

The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted
therapy (TT) has dramatically improved the prognosis of various cancer types. However …

Objectives To develop a model using radiomic features extracted from MR images to
distinguish radiation necrosis from tumour progression in brain metastases after Gamma …

Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …

Purpose Cerebral radiation necrosis is a complication of radiation therapy that can be seen
months to years following radiation treatment. Differentiating radiation necrosis from tumor …

Simple Summary Positron emission tomography (PET) imaging is increasingly used to
supplement MRI in the management of patient with brain tumors. In this article, we provide a …

Introduction: Radionecrosis (RN) represents the main complication of stereotactic
radiotherapy (SRT) for brain metastases. It may be observed in up to 34% of cases at 24 …

Arterial spin labeling (ASL) is a magnetic resonance imaging perfusion technique that
enables quantification of cerebral blood flow (CBF) without the use of intravenous …